Neutralizing and binding activities against SARS‐CoV ‐1/2, MERS‐CoV , and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan-Reference-Cited by-同舟云学术

Neutralizing and binding activities against SARS‐CoV ‐1/2, MERS‐CoV , and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan

Published:2020-10-26 Issue:2 Volume:61 Page:356-360
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kubota‐Koketsu Ritsuko¹,Terada Yutaka²,Yunoki Mikihiro³^ORCID,Sasaki Tadahiro¹,Nakayama Emi E.¹,Kamitani Wataru²⁴,Shioda Tatsuo¹

Affiliation:

1. Department of Viral Infections Research Institute for Microbial Diseases, Osaka University Suita Japan

2. Laboratory of Clinical Research on Infectious Diseases Research Institute for Microbial Diseases, Osaka University Suita Japan

3. Research and Development Division Japan Blood Products Organization Tokyo Japan

4. Department of Infectious Diseases and Host Defense, Graduate School of Medicine Gunma University Maebashi Japan

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16161

Reference16 articles.

1. The International Committee on Taxonomy of Viruses.Coronavirus ICTV 9th report(2011).https://talk.ictvonline.org/ictv-reports/ictv_9th_report/positive-sense-rna-viruses-2011/w/posrna_viruses/222/coronaviridae. Accessed September 1 2020.

2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

3. Deployment of convalescent plasma for the prevention and treatment of COVID-19

4. Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review

5. The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful management of persistent COVID-19 using combination antiviral therapy (nirmatrelvir/ritonavir and remdesivir) and intravenous immunoglobulin transfusion in an immunocompromised host who had received CD20 depleting therapy for follicular lymphoma;Journal of Infection and Chemotherapy;2024-08

2. Terpenes and cannabidiol against human corona and influenza viruses–Anti-inflammatory and antiviral in vitro evaluation;Biotechnology Reports;2024-03

3. Immunoglobulin replacement products confer in vivo protection against SARS-CoV-2 XBB.1.5 Omicron variant despite poor neutralizing activity;JCI Insight;2024-01-04

4. Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters;Frontiers in Immunology;2023-05-25

5. Changes in Anti–SARS-CoV-2 Antibody Titers of Pooled Plasma Derived From Donors in Japan: A Potential Tool for Mass-Immunity Evaluation;The Journal of Infectious Diseases;2023-05-24